$PRGO News

Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y

Assessing Perrigo (PRGO) Valuation After Weak Q1 Results And Lowered Guidance

Perrigo Company plc Q1 2026 Earnings Call Summary

Perrigo Company plc (PRGO) Q1 2026 Earnings Call Transcript

Perrigo (PRGO) Q1 Earnings Beat Estimates

Perrigo Company plc 2026 Q1 - Results - Earnings Call Presentation

Perrigo Co PLC (NYSE:PRGO) Gains in Pre-Market as Q1 2026 EPS Beat Offsets Revenue Miss

Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations

Perrigo Reports Q1 2026 Results: Full Earnings Call Transcript

Perrigo Affirms FY2026 Adj EPS Guidance of $2.25-$2.55 vs $2.11 Est; Affirms FY2026 Sales Guidance of $4.019B-$4.189B vs $4.114B Est

Perrigo Q1 Adj. EPS $0.43 Beats $0.31 Estimate, Sales $939.000M Miss $1.031B Estimate

How Investors Are Reacting To Perrigo (PRGO) Dermacosmetics Sale, Dividend Payout, And Infant Formula Strains

Perrigo Completes Divestiture of Dermacosmetics Business

ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth

Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

Perrigo Announces Quarterly Dividend

Perrigo: Positioning Through A Thesis Reset

Is Perrigo (PRGO) Offering Value After A 49.9% One Year Share Price Decline?

Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026

Watching Perrigo; Traders Circulate Unconfirmed Rumor From M&A Blog Suggesting The Company Is Seeing Takeover Interest